Estadístiques de Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Visites totals

views
Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib 3

Visites totals per mes

views
December 2024 0
January 2025 2
February 2025 0
March 2025 0
April 2025 0
May 2025 1
June 2025 0

Visites al fitxer

views
Jaramillo_hae_late.pdf 31